The changing face of oncology market access

17/06/2013

Cathy Wright

Cathy Wright of Succinct Healthcare Communications explores the changing face of oncology market access.There's no doubt that the NHS in England is going through a period of unprecedented change, and...

Pharma gets social: Sanofi Iberia equips doctors for digital engagemen…

17/06/2013

Daniel Ghinn

In his latest 'pharma gets social' article, Daniel Ghinn discusses Sanofi's new social media tool to help improve digital engagement between pharma and doctors.(Continued from "Pharma gets social: Novartis has...

Tunnah’s musings: Doctors 2.0 & You– it’s not about the technolog…

14/06/2013

Paul Tunnah

Having attended the annual Doctors 2.0 & You conference on healthcare social media and technology for the first time, Paul Tunnah is musing on some of the things he learned...

Managing relocation of talent

14/06/2013

Sean Ridley

Being head hunted can be an exciting experience but the reality is that the opportunity will almost never be on your doorstep. Here, Sean Ridley analyses the approach to managing...

J&J announces $1bn deal to acquire Aragon Pharma

17/06/2013

Hannah Blake

Johnson & Johnson is to acquire cancer-focused company, Aragon Pharmaceuticals, in a definitive agreement worth up to US $1 billion.Aragon is a discovery and development company focused on drugs to...

Roche’s Avastin approved to treat aggressive brain cancer in Japan

17/06/2013

Hannah Blake

The Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Roche's Avastin for the treatment of rare disease, malignant glioma, in Japan. Avastin (bevacizumab) has also been approved for...

US FDA approves Amgen’s Xgeva for rare bone condition

14/06/2013

Hannah Blake

The US FDA has expanded the approved use of Amgen's Xgeva to treat giant cell tumor of the bone (GCTB), which is a rare and usually non-cancerous tumor. The regulatory...

Human genes cannot be patented, says US Supreme Court

14/06/2013

Hannah Blake

The US Supreme Court has ruled that natural human genes cannot be patented.This decision follows a case between Myriad Genetics and the Association for Molecular Pathology, regarding controversial breast cancer...

Perspectives on personalised healthcare …

Executive perspectives: Bruno Strigini

Doctors hold the key to understanding pa…

Carly Brown

Pharma is recognising the increasing importance of the patient voice in providing feedback on how medicines are utilised in a real-world setting and the impact they are having on outcomes....

Outcomes shape the new payer networks fo…

Marcelo Fantoni

The definition of the payer and the way in which healthcare spending decisions are made is changing, as complex networks of payers and clinicians become the new stakeholders with which...

Publishing white papers on pharmaphorum

Paul Tunnah

As a new feature on pharmaphorum, we unveil pharmaceutical industry white papers as part of our media section. Download this one page document to understand how to publish your deep...